A Study of Velaglucerase Alfa (VPRIV) in Chinese Children, Teenagers, and Adults With Type 1 Gaucher Disease
NCT05529992
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Gaucher Disease
Interventions
DRUG:
Velaglucerase Alfa
Sponsor
Takeda